July 2026– date –
-
HCA Healthcare Announces Promising Results for CRISPR Gene Therapy Exa-cel in Pediatric Sickle Cell Disease and Beta-Thalassemia Patients
HCA Healthcare USA Overview HCA Healthcare has announced findings from a New England Journal of Medicine study, sponsored by Vertex Pharmaceuticals, demonstrating that the CRISPR gene-editing therapy exa-cel shows promising results in pe... -
CRISPR’s First Clinical Evidence for HBV cccDNA Elimination, Prime Editing Advances to Inaugural Human Trial
CRISPR Medicine News USA Overview Precision Biosciences' PBGENE-HBV has demonstrated the first clinical evidence of eliminating viral cccDNA in chronic Hepatitis B patients, marking a significant milestone for CRISPR-based therapies in i... -
3D Bioprinted Organoids Pave the Way for Clinical Translation in Oncology, Regenerative Medicine, and Drug Discovery
Reproductive Biology (Oxford Academic) UK Overview 3D bioprinted organoids are demonstrating significant advances in oncology, regenerative medicine, and drug discovery by more faithfully replicating in vivo tissue structures and functio... -
Continuous Manufacturing and Automated Closed Systems Revolutionize Cell & Gene Therapy Production for Enhanced Efficiency and Quality
News-Medical.net UK Overview The commercial manufacturing of cell and gene therapies is being transformed by the imperative for continuous processing and automated closed systems to overcome current scalability and quality challenges. Th... -
BioNetwork Consulting Introduces Agentic AI for Clinical Operations, Offering Expertise in Gen AI Governance and Real-World Evidence Strategy
BioNetwork Consulting USA Overview BioNetwork Consulting now offers specialized expertise in integrating Agentic AI into Clinical Operations, with a strong focus on Generative AI (Gen AI) Governance & Regulatory Compliance, and Real-... -
Kanerika Unveils Custom LLM Development Services for Enterprises, Emphasizing Robust Governance and Compliance for Regulated Industries
Kanerika India Overview Kanerika has launched custom LLM development services for enterprise teams, with a strong focus on enterprise-grade governance and compliance for regulated industries. Their solutions feature a governed LLM archit... -
SK bioscience Leads Gates Foundation-Funded AI Platform ‘ROTOR’ to Enhance Vaccine Development Decisions, Focusing on Next-Gen Rotavirus Vaccines
PR Newswire South Korea Overview SK bioscience is leading the Gates Foundation-funded ROTOR project, an AI-powered platform for evidence-based clinical development decision-making in vaccine development, with PATH and Slalom as global co... -
Anthropic Launches ‘Claude Science’ for Pharmaceutical Researchers to Aid Drug Discovery and Improve Patient Experience
pharmaphorum USA Overview Anthropic has launched "Claude Science," a new offering specifically tailored for pharmaceutical researchers to aid in drug discovery processes. This initiative aims to address critical topics impacting healthca... -
XPENG Unveils ‘X-Mind’ Framework for Predictive Autonomous Driving AI, Completing Physical AI Foundation Model with ‘Future-Foresight Brain’
PRNewswire China Overview XPENG unveiled its 'X-Mind' framework at the CVPR 2026 Workshop on Foundation Model, completing its Physical AI foundational model roadmap. X-Mind, combined with X-World and X-Foresight, empowers vehicles with a... -
AI in Life Science Market Projected to Reach $69.34 Billion by 2031, Driven by Advanced AI Architectures: GlobeNewswire Report Overview
GlobeNewswire Global Overview This article provides an overview of a market research report distributed by GlobeNewswire. The AI in life science market is projected to reach USD 69.34 billion by 2031, growing at a CAGR of 26.3% from USD ...
